CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF TOXICODERMA, INCLUDING THAT WITH SECONDARY PYODERMA

V. Yu Udzhukhu; A. S Medvedeva; M. A Ivanokova

doi:10.17816/dv36770

Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (5) : 44 -46. DOI: 10.17816/dv36770

Articles

research-article

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF TOXICODERMA, INCLUDING THAT WITH SECONDARY PYODERMA

Author information +

History +

PDF

Abstract

The role of immunometabolic disorders in the development of drug-induced toxicoderma was studied. A total of 59 patients with clinical variants of toxicoderma were observed. Immunological studies detected disorders in the immune homeostasis, characterized by disproportion of the cytokine profile, adhesion molecules, and Toll-like receptors, as well as in natural resistance of patients with toxicoderma.

Keywords

toxicoderma / immune homeostasis / interleukins / nitric oxide / Toll-like receptors / adhesion molecules

Cite this article

Download citation ▾

V. Yu Udzhukhu, A. S Medvedeva, M. A Ivanokova. CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF TOXICODERMA, INCLUDING THAT WITH SECONDARY PYODERMA. Russian Journal of Skin and Venereal Diseases, 2012, 15(5): 44-46 DOI:10.17816/dv36770

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Веселова Л.В., Хамаганова И.В., Савина М.И. Патогенетическая терапия аллергодерматозов. Экспериментальная и клиническая дерматокосметология 2007; 1: 21—5.

[2]	Землякова С.С., Иванов О.Л., Львов А.Н., Феденко Е.С. Аллергический контактный дерматит и ассоциированные аллергодерматозы: современные представления об этиологии, патогенезе и диагностике. Рос. журн. кож. и вен. бол. 2010; 4: 47—51.

[3]	Кузьмина Л.П., Измерова Н.И., Коляскина М.М. Роль полиморфных генов системы биотрансформации ксенобиотиков в патогенезе профессиональных аллергодерматозов. Медицина труда и промышленная экология 2011; 7: 17—23.

[4]	Petkov T., Pehlivanov G., Grozdev I., Kavaklieva S., Tsankov N., et al. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome. Eur. J. Dermatol. 2007: 17(5): 422—7.

[5]	Borch J.E., Andersen K.E., Bindslev-Jensen C. Cutaneous adverse drug reactions seen at a university hospital department of dermatology. Acta Derm. Venereol. 2006; 86(6): 523—7.

[6]	Wei C.Y., Ko T.M., Shen C.Y., Chen Y.T. A recent update of pharmacogenomics in drug-induced severe skin reactions. Drug. Metab. Pharmacokinet. 2012; 27(1): 132—41.

[7]	Martin T., Li H. Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin. Med. J. (Engl). 2008; 121(8): 756—61.

[8]	Roychowdhury S., Svensson C.K. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. Am. Ass. Pharm. Sci. J. 2005; 7(4): E834—46.

[9]	Schäfer T., Böhler E., Ruhdorfer S., Weigl L., Wessner D., Heinrich J., et al. Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy. 2001; 56(12): 1172—9. doi: 10.1034/j.1398-9995.2001.00196.x

[10]	Измерова Н.И., Иванова Л.А., Чикин В.В., Савельева A.A. Новые перспективы в терапии профессиональных аллергодерматозов (обзор литературы) Медицина труда и промышленная экология 2009; 9: 37—41.

[11]	Torres M.J., Mayorga C., Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J. Invest. Allergol. Clin. Immunol. 2009; 19(2): 80—90.

[12]	Son Y.M., Lee J.R., Roh J.Y. Causality assessment of cutaneous adverse drug reactions. Ann. Dermatol. 2011; 23(4): 432—8. doi: 10.5021/ad.2011.23.4.432.